Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001390478-16-000128
Filing Date
2016-07-18
Accepted
2016-07-18 18:15:16
Documents
1
Period of Report
2016-07-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4031
  Complete submission text file 0001390478-16-000128.txt   5698
Mailing Address 1801 CENTURY PARK EAST LOS ANGELES CA 90067
Business Address
Hillsberg Sanford (Reporting) CIK: 0001297696 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33958 | Film No.: 161772218

Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Issuer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations